DRUGS DOUSAGE, ACTION DESIRED EFFECT NURSING RESPONSIBILITIES

ROUTE AND
FREQUENCY
GENERIC NAME: 5 mg SL now Unknown, though to inhibit Given to our To potentiate effectiveness of the drug:
Nifedipine then q 6 calcium ion influx across patient to  Instruct patient to not to crew the med
cardiac and smooth muscle manage (soft gel)
BRAND NAME: cells, decrease contractility hypertension.  Advise patient to avoid taking drug with
and oxygen demand. Also grapefruit juice
may dilate coronary artery  Tell patient to protect the capsule from
GENERAL and arterioles. direct sunlight and moisture and to
CLASSIFICATION: restore at room temperature
Anti- Ensure safe use of the drug:
hypertensives  Monitor patient blood pressure
 Contraindicated to patient with
SPECIFIC hypersensitivity to drug
CLASSIFICATION:  Watch for symptoms of heart failure
Calcium  Perform daily weighting and monitor for
Channel swelling
Blocker  Monitor for adverse reaction such as:
1. Dizziness
DATE ORDERED: 2. Light headedness
07-29-10 3. Headache
4. Weakness
5. Peripheral edema
6. Hypotension
7. Palpitation
8. Heart failure
 DRUGS DOUSAGE, ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
ROUTE AND
FREQUENCY
GENERIC NAME: 4x AS on LE Unknown, though to Given to treat To potentiate effectiveness of the drug:
Mupirocin inhibit bacterial protein infected wounds/  Clean and dry affected areas before
and RNA synthesis cuts applying
BRAND NAME:  Observe aseptic technique when
applying the drug

SPECIFIC Ensure safe use of the drug:

CLASSIFICATION:  Use medication for external only
Topical drug  Can cover affected areas with bandage /
gauze
GENERAL  Monitor side effects such as:
CLASSIFICATION: 1. Burn
Local anti- 2. Itching
infectives 3. Stinging

DATE ORDERED:
07-29-10
 DRUG DOUSAGE, ACTION DESIRED EFECT NURSING RESPONSIBILITIES
ROUTE AND
FREQUENCY
GENERIC NAME: 25 mg ½ tab Inhibits ACE, preventing Given to our To potentiate effectiveness of the drug:
Captopril BID OD conversion of angiotensin patient to  Instruct to take drug 1 hr before meal
I to angiotensin II , a decrease the Ensure safe use of the drug:
BRAND NAME: potent vasoconstrictor, blood pressure/  Monitor pt. BP and RR frequently
less angiotensin II management of  Uses cautiously c pt. c renal/ impaired
decreases peripheral hypertension renal function
GENERAL arterial resistance,  Instruct pt/ SO to report: swelling of
CLASSIFICATION: decreases aldosterone face, lips and mouth/ DOB
Anti- secretion w/c reduces  Advise to avoid sudden position change
hypertensives sodium and water to minimize hypotension
retention and lowers  Monitor for protenuria every 2-4 wks for
SPECIFIC blood pressure the first 3 mos of therapy to decrease
CLASSIFICATION: renal function
Angiotensin  Monitor adverse reaction such as:
Converting 1.dizziness
Enzymes inhibitor 2. fainting
3.headache
DATE ORDERED: 4.malaise/fatigue
07-30-10 5.fever
6.diarrhea
7. dry mouth
8. nausea and vomiting
9. protenuria

DRUGS DOUSAGE, ACTION DESIRED EFFECT NURSING RESPONSIBILITIES

 ROUTE AND
FREQUENCY
GENERIC NAME: 30 mg TIV q 12 Inhibit the reabsorption This drug is given To potentiate effectiveness of the drug:
Furosemide c BP precaution of sodium and chloride in to the patient to  Performed aseptic technique in
< 90/60 the proximal and distal treat edema and to handling and administering of the drug
BRAND NAME: tubules as well as the prevent Ensure safe use of the drug:
Lasix ascending loop of Henle: hypertension  Check BP before giving med
this result in the  Monitor weight and input and output
GENERAL excretion of sodium for edema
CLASSIFICATION: chloride and to a lesser  Advise patient not to consume
Loop Diuretics degree, potassium and excessive amount of coffee, tea, or
bicarbonate ions cola;may interefere with BP control and
DATE ORDERED: drug effectiveness
07-29-10  Encourage to comply with additional
antihypertensive intervension such
as;weight reduction, low sodium diet,
regular exercise and stress
management
 When given IV give slowly for 1-2 mins
 Given in the morning
 Discuss need to increase foods high in
potassium like; Banana,watermelon,
 Monitor ototoxicity
 Advise patient to report immediately;
ringing in ears, abdominal pain, sore
throat and fever
 Instruct patient to report adverse
reaction such as:
1. Muscle weakness
2. Dizziness
3. Numbness and tingling
4. Blurred vision
5. Nausea and vomiting
 DRUGS DOUSAGE, ACTION DESIRED NURSING RESPONSIBILITIES
ROUTE AND EFFECT
FREQUENCY
GENERIC NAME: 790000 IU TIV q Inhibit cell wall Given to our To potentiate effectiveness of the drug:
Penicillin G 6 ANST ( ) synthesis during patient to treat  Ensure skin testing
bacterial systemic  Performed aseptic technique in administering
BRAND NAME: multiplication infection Ensure safe use of the drug:
 Administer the drug slow
 Tell patient to report immediately rash, chills
GENERAL and fever
CLASSIFICATION:  Use sterile water, isotonic saline in mixing for
Antibiotics desired strength
 Donot mix with other medications like
DATE/TIME aminophylline, ascorbic acid, gentmicyn and
ORDERED: heparin
07-29-10  Monitor adverse reaction such as:
4:30PM 1. Neuropathy
2. Seizures
3. Hallucinations
4. Agitation
5. Confusion
6. Dizziness
7. Fatigue

DRUG DOUSAGE, ACTION DESIRED EFFECT NURSING RESPONSIBILITIES

 ROUTE AND
FREQUENCY
GENERIC NAME: 500 mg 1 tab/ Drug may relieve fever Given to our To potentiate effectiveness of the drug:
Paracetamol 250 mg/ 5 ml give through central action patient to  Do handwashing before handling med
10 ml in the hypothalamic decrease body  Performed TSB
BRAND NAME: heat regulating center. temperature  Use light clothings and provide proper
ventilation
Ensure safety of the patient
GENERAL  Use cautiously in pt hypersensitive to
CLASSIFICATION: drug
Non-opiod  Monitor hematologic status because it
analgesic and can decrease RBC,WBC and platelets
antipyretics  Monitor adverse reaction such as:
1.Hemolytic Anemia
DATE ORDERED: 2. Neutropenia
08-03-10 3.Leukopenia
4. Pancytopenia
5. Jaundice
6. Hypoglycemia
7. rash

DRUG DOUSAGE, ACTION DESIRED NURSING RESPONSIBILITIES

 ROUTE AND EFFECT
FREQUENCY
GENERIC NAME: 250 mg 7-8 ml 2x Second generation Given to our To potentiate effectiveness of the drug:
Cefuroxime a day cephalosporin that patient to treat  Suspension will be given with foods
sodium inhibits cell wall systemic  Do hand washing before handling the
synthesis, thus infection med
BRAND NAME: promoting osmotic Ensure safe use of the drug
instability, usually  Report signs of anorexia, dizziness, pale
bactericidal. skin and SOB
GENERAL  Drug regimen (therapy given for 10 days)
CLASSIFICATION:  Monitor adverse reaction such as:
Cephalosporin 1. Diarrhea
2. Nausea
SPECIFIC 3. Rash
CLASSIFICATION:
2nd generation
cephalosporin

DATE/TIME
ORDERED:
08-08-10
 DRUG DOSAGE, ROUTE ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
AND FREQUENCY
GENERIC NAME: 500 mg 1 cap 3x a Inhibit cell wall Given to our To potentiate effectiveness of the drug:
Sumapen day synthesis during patient to treat  Taken in an empty stomach
bacterial multiplication systemic  Taken 1 hr before / 2 hr after meals
BRAND NAME: infection Ensure safe use of the drug:
 Contraindicated to pt with allergies to
penicillin
GENERAL  Use cautiously to patient c renal
CLASSIFICATION: impairment
Anti- infectives  Monitor for adverse reactions such as:
1. GI disturbances
DATE ORDERED: 2. Allergic skin reactions
08-08-10 3. Blood disorders
4. Anaphylaxis
5. Black hairy tongue
6. Neuropathy
 DRUG DOSAGE, ROUTE ACTION DESIRED EFFECT NURSING RESPONSIBILITIES
AND FREQUENCY
GENERIC NAME: 25 mg TIV q8 Competitively inhibit Given as a To potentiate effectiveness of the drug:
Ranitidine action of histamine on prophylaxis for  Ensure skin testing
the h2 at receptor sites other drug given  Aseptic technique in administering med
BRAND NAME: of parietal cells, such as To ensure safe use of the drug:
Zantac decreasing gastric acid cefuroxime  Avoid food that can increase gastric
secretion secretion such as: coffee, tea, soda and
GENERAL spicy foods
CLASSIFICATION:  Use cautiously in patient with impaired
Anti- ulcer renal function
 Advise to report abdominal pain and
SPECIFIC blood in stool / emesis
CLASSIFICATION:  monitor adverse reaction such as:
H2 receptor 1. vertigo
antagonist 2. malaise
3. headache
DATE ORDERED: 4. blurred vision
08-02-10 5. jaundice
DRUG STUDY